Loading...
XJPX7702
Market cap65mUSD
Jan 17, Last price  
418.00JPY
1D
-0.71%
1Q
-13.46%
Jan 2017
-31.02%
Name

JMS Co Ltd

Chart & Performance

D1W1MN
XJPX:7702 chart
P/E
—
P/S
0.16
EPS
—
Div Yield, %
4.05%
Shrs. gr., 5y
0.08%
Rev. gr., 5y
2.38%
Revenues
65.29b
+2.43%
43,545,513,00044,400,209,00045,124,000,00045,587,000,00046,836,000,00049,068,000,00053,860,000,00055,401,000,00057,636,000,00055,574,000,00056,520,000,00058,059,000,00058,569,000,00057,578,000,00058,169,000,00063,740,000,00065,292,000,000
Net income
-36m
L
1,015,786,0001,180,114,0001,506,000,0001,291,000,000942,000,0001,277,000,000207,000,000139,000,000754,000,0001,182,000,000631,000,0001,160,000,0001,977,000,0001,736,000,000826,000,000281,000,000-36,000,000
CFO
3.14b
+26.36%
3,107,830,0002,394,062,0005,320,000,0003,281,000,0001,754,000,0002,545,000,0001,206,000,0002,901,000,0004,526,000,0004,675,000,0002,666,000,0004,353,000,0003,565,000,0003,739,000,0004,399,000,0002,485,000,0003,140,000,000
Dividend
Mar 28, 20250 JPY/sh

Profile

JMS Co.,Ltd. manufactures, sells, exports, and imports medical devices and pharmaceuticals in Japan and internationally. The company offers infusion and transfusion sets, infusion sets with a needleless access port, disposable needles and syringes, safety scalp vein sets, safety venous indwelling catheters, extension tubes, oral/enteral nutrition systems, infusion and syringe pumps, semisolid nutrition feeding devices, blood bags, blood collection scale and mixers, high-frequency tube sealers, and serum collection sets for infusion and transfusion therapy. It also provides general medical supplies, including latex surgeon's gloves and examination gloves, plastic gloves, treatment sheets, surgical gowns, masks and caps, drainage bags, and surgical tapes used in medical institutions. In addition, the company offers central dialysate delivery systems, hemodialysis machines, AV fistula needles, accidental needlestick prevention systems, hemodialysis blood tubing sets, dialyzers, prefilled syringes, hemodialysis kits, single patient dialysis machines, dialysis solution for CAPD, and automatic peritoneal dialysis machines for hemodialysis and peritoneal dialysis. Further, it provides cardiovascular therapy products, such as cardiopulmonary equipment, membrane oxygenators, heat exchangers, pacemakers, microcatheters, and cardiopulmonary blood tubing sets. JMS Co.,Ltd. was incorporated in 1947 and is headquartered in Hiroshima, Japan.
URL
https://www.jms.cc/
IPO date
Dec 01, 1981
Employees
5,650
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
65,292,000
2.43%
63,740,000
9.58%
58,169,000
1.03%
Cost of revenue
65,161,000
62,586,000
56,803,000
Unusual Expense (Income)
NOPBT
131,000
1,154,000
1,366,000
NOPBT Margin
0.20%
1.81%
2.35%
Operating Taxes
191,000
358,000
261,000
Tax Rate
145.80%
31.02%
19.11%
NOPAT
(60,000)
796,000
1,105,000
Net income
(36,000)
-112.81%
281,000
-65.98%
826,000
-52.42%
Dividends
(415,000)
(415,000)
(414,000)
Dividend yield
3.17%
3.25%
2.78%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
14,604,000
8,090,000
8,351,000
Long-term debt
13,813,000
11,889,000
10,913,000
Deferred revenue
6,000
840,000
958,000
Other long-term liabilities
1,485,000
494,000
471,000
Net debt
13,275,000
8,956,000
7,752,000
Cash flow
Cash from operating activities
3,140,000
2,485,000
4,399,000
CAPEX
(2,642,000)
(3,556,000)
(3,261,000)
Cash from investing activities
(4,239,000)
(3,691,000)
(3,677,000)
Cash from financing activities
4,775,000
525,000
(499,000)
FCF
(4,873,000)
(2,606,000)
(98,000)
Balance
Cash
10,308,000
6,329,000
6,813,000
Long term investments
4,834,000
4,694,000
4,699,000
Excess cash
11,877,400
7,836,000
8,603,550
Stockholders' equity
30,588,000
63,624,000
62,154,000
Invested Capital
57,276,600
51,804,000
48,402,450
ROIC
1.59%
2.33%
ROCE
0.19%
1.93%
2.39%
EV
Common stock shares outstanding
24,471
24,443
24,428
Price
535.00
2.29%
523.00
-14.26%
610.00
-37.63%
Market cap
13,091,759
2.41%
12,783,869
-14.21%
14,901,035
-37.58%
EV
26,540,759
56,966,869
57,968,035
EBITDA
3,845,000
4,747,000
4,725,000
EV/EBITDA
6.90
12.00
12.27
Interest
220,000
167,000
159,000
Interest/NOPBT
167.94%
14.47%
11.64%